Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Aprea Therapeutics, Inc. (APRE)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aprea Therapeutics, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Aprea Therapeutics, Inc. since 2005.
The reporting company's ticker symbol is APRE. The reporting company's CIK number is 1781983.
The total value of stock buying since 2005 is $29,388,495.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $18,477.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-10-07||Healthcap Vii Gp S.a. (10% Owner)||Buy||266,667||15.00||4,000,005|
|2019-10-07||Attar Eyal C. (SVP, Chief Medical Officer)||Buy||400||15.00||6,000|
|2019-10-07||Seizinger Bernd R.||Option Ex||263,970||.07||18,477|
|2019-10-07||Korbel Gregory Alan (VP of Business Dev't)||Buy||500||15.00||7,500|
|2019-10-07||Versant Vantage I Gp-gp, Llc||Buy||333,333||15.00||4,999,995|
|2019-10-07||Parmar Kush (10% Owner)||Buy||333,333||15.00||4,999,995|
|2019-10-07||Coiante Scott M (SVP, Chief Financial Officer)||Buy||2,500||15.00||37,500|
|2019-10-07||Versant Venture Capital V, L.p.||Buy||333,333||15.00||4,999,995|
|2019-10-07||Schade Christian S (President & CEO)||Buy||11,000||15.00||165,000|
|2019-10-07||Henneman John B Iii||Buy||5,000||15.00||75,000|
Insider trading activities including stock purchases, stock sales, and option exercises of APRE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aprea Therapeutics, Inc. (symbol APRE, CIK number 1781983) see the Securities and Exchange Commission (SEC) website.